HHS awards $47.2M contract for surgical and medical instruments to Global Life Sciences Solutions USA LLC

Contract Overview

Contract Amount: $47,187 ($47.2K)

Contractor: Global Life Sciences Solutions USA LLC

Awarding Agency: Department of Health and Human Services

Start Date: 2026-04-09

End Date: 2027-04-08

Contract Duration: 364 days

Daily Burn Rate: $130/day

Competition Type: NOT COMPETED UNDER SAP

Number of Offers Received: 1

Pricing Type: FIRM FIXED PRICE

Sector: Healthcare

Official Description: GLOBAL LIFE SCIENCES SOLUTIONS USA LLC:1107247 [26-001651]

Place of Performance

Location: MARLBOROUGH, MIDDLESEX County, MASSACHUSETTS, 01752

State: Massachusetts Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $47,187 to GLOBAL LIFE SCIENCES SOLUTIONS USA LLC for work described as: GLOBAL LIFE SCIENCES SOLUTIONS USA LLC:1107247 [26-001651] Key points: 1. The contract value of $47.2 million over one year represents a significant investment in medical supplies. 2. The award was made on a sole-source basis, raising questions about potential cost efficiencies and market competition. 3. The fixed-price contract type aims to control costs, but the lack of competition could limit price discovery. 4. The duration of 364 days suggests a need for ongoing supply, potentially indicating a critical or recurring requirement. 5. The National Institutes of Health (NIH) is the primary agency, indicating a focus on research and development support. 6. The product service code (PSC) is not specified, making it difficult to benchmark against similar instrument procurements.

Value Assessment

Rating: questionable

Benchmarking the value of this $47.2 million contract is challenging due to the lack of detailed product information and the sole-source award. Without competitive bids, it's difficult to ascertain if the pricing reflects fair market value. Comparing it to similar sole-source procurements for surgical and medical instruments by NIH or other agencies would be necessary for a more robust assessment. The fixed-price nature is a positive cost control measure, but the absence of competition limits the ability to confirm value for money.

Cost Per Unit: N/A

Competition Analysis

Competition Level: sole-source

This contract was awarded on a sole-source basis, meaning it was not competed. This approach is typically used when only one responsible source is available or when a compelling justification exists for not seeking competition. The lack of multiple bidders means there was no opportunity for price negotiation or comparison among different suppliers, potentially leading to higher costs for the government.

Taxpayer Impact: Taxpayers may be paying a premium for these instruments due to the absence of competitive bidding. The government did not leverage market forces to secure the best possible price.

Public Impact

The primary beneficiaries are researchers and medical professionals at the National Institutes of Health (NIH) who will receive essential surgical and medical instruments. The contract supports the ongoing operations and research activities of NIH, contributing to advancements in health and medicine. The geographic impact is primarily within the United States, where NIH facilities are located and where the instruments will be utilized. The contract ensures the availability of critical supplies, supporting the healthcare and medical research workforce.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Sole-source award limits price competition and potentially increases costs for taxpayers.
Lack of detailed product information hinders thorough value-for-money assessment.
The contract's duration and value suggest a significant, potentially recurring need that warrants future competitive analysis.

Positive Signals

Fixed-price contract type helps to control costs and provides budget certainty.
Award to Global Life Sciences Solutions USA LLC ensures continuity of supply for critical NIH operations.
The contract supports vital research and medical activities within the Department of Health and Human Services.

Sector Analysis

The surgical and medical instrument manufacturing sector is a critical component of the healthcare industry, providing essential tools for diagnosis, treatment, and research. This contract falls within the broader healthcare and life sciences market, which is characterized by innovation, regulatory oversight, and significant government procurement. Benchmarking this award against other federal procurements for similar instruments is difficult without a specific product service code, but the overall market for medical devices and instruments is substantial, with numerous players ranging from large corporations to specialized manufacturers.

Small Business Impact

The data indicates that this contract was not set aside for small businesses (ss: false, sb: false). Therefore, there are no direct subcontracting implications for small businesses stemming from a set-aside provision. However, the prime contractor, Global Life Sciences Solutions USA LLC, may engage small businesses as subcontractors, depending on their own procurement strategies and the nature of the instruments supplied. Further investigation into the contractor's subcontracting plan would be needed to assess the impact on the small business ecosystem.

Oversight & Accountability

Oversight for this contract will primarily reside with the Department of Health and Human Services (HHS) and the National Institutes of Health (NIH). As a purchase order, it may fall under the agency's internal procurement oversight processes. Transparency regarding the justification for the sole-source award and the pricing structure would be beneficial. Inspector General jurisdiction would apply if any fraud, waste, or abuse is suspected.

Related Government Programs

Medical Supplies and Equipment
Research and Development Contracts
Healthcare Services Procurement
Federal Supply Schedule (FSS) Contracts

Risk Flags

Sole-source award may indicate lack of competition.
Limited transparency on justification for sole-source award.
Lack of specific product details hinders value assessment.

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $47,187 to GLOBAL LIFE SCIENCES SOLUTIONS USA LLC. GLOBAL LIFE SCIENCES SOLUTIONS USA LLC:1107247 [26-001651]

Who is the contractor on this award?

The obligated recipient is GLOBAL LIFE SCIENCES SOLUTIONS USA LLC.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (National Institutes of Health).

What is the total obligated amount?

The obligated amount is $47,187.

What is the period of performance?

Start: 2026-04-09. End: 2027-04-08.

What is the specific justification for awarding this contract on a sole-source basis to Global Life Sciences Solutions USA LLC?

The provided data indicates the contract was 'NOT COMPETED UNDER SAP' (Simplified Acquisition Procedures), and it is listed as 'sole-source'. However, the specific justification for this sole-source determination is not detailed in the provided data. Typically, sole-source awards are made when only one responsible source is available, or when there is a compelling urgency, a unique capability, or a specific national security reason. Without further documentation from the Department of Health and Human Services (HHS) or the National Institutes of Health (NIH), the precise rationale remains unclear. This lack of transparency can raise concerns about whether the government fully explored competitive options to ensure the best value for taxpayer dollars.

How does the pricing of this contract compare to similar surgical and medical instrument procurements by federal agencies?

Direct price comparison is difficult without knowing the specific types of surgical and medical instruments being procured under this $47.2 million contract. The data only provides the North American Industry Classification System (NAICS) code 339112 for Surgical and Medical Instrument Manufacturing. To conduct a meaningful benchmark, one would need to identify comparable contracts for the same or very similar instruments, ideally awarded competitively. Given this contract was sole-source, it is less likely to reflect the lowest possible market price achievable through competition. A review of historical NIH or other agency procurements for similar instrument categories, especially those awarded competitively, would be necessary to assess if the pricing is reasonable.

What are the potential risks associated with awarding a contract of this magnitude on a sole-source basis?

The primary risk associated with a sole-source award of this magnitude ($47.2 million) is the potential for inflated pricing due to the lack of competitive pressure. Without multiple bidders vying for the contract, the government may not achieve the most cost-effective outcome. There's also a risk of reduced innovation, as there's no incentive for the sole provider to offer novel solutions or improved product offerings that might arise from a competitive environment. Furthermore, a sole-source award can limit the government's flexibility if the contractor fails to perform adequately, as finding an alternative supplier quickly could be challenging.

What is the expected performance period and delivery schedule for these instruments?

The contract has a duration of 364 days, with a start date of April 9, 2026, and an end date of April 8, 2027. This indicates a one-year performance period. The award is a 'PURCHASE ORDER' with a 'FIRM FIXED PRICE' type, suggesting that the contractor is obligated to deliver the specified surgical and medical instruments within this timeframe at the agreed-upon price. While the exact delivery schedule for individual items is not detailed, the contract structure implies regular or scheduled deliveries to meet the ongoing needs of the National Institutes of Health (NIH) during the contract period.

What is the historical spending pattern for surgical and medical instruments by the National Institutes of Health (NIH)?

The provided data focuses on a single contract award and does not offer historical spending patterns for surgical and medical instruments by the NIH. To determine historical spending, one would need to access federal procurement databases (like USASpending.gov) and query for spending related to NAICS code 339112 or relevant Product Service Codes (PSCs) by the NIH over several fiscal years. Analyzing this historical data would reveal trends in contract values, types of instruments procured, and the extent to which these procurements were competed versus awarded sole-source. This context is crucial for understanding if the current $47.2 million award is an anomaly or part of a consistent spending trend.

Industry Classification

NAICS: Manufacturing › Medical Equipment and Supplies Manufacturing › Surgical and Medical Instrument Manufacturing

Product/Service Code: MAINT, REPAIR, REBUILD EQUIPMENT › MAINT, REPAIR, REBUILD OF EQUIPMENT

Competition & Pricing

Extent Competed: NOT COMPETED UNDER SAP

Solicitation Procedures: SIMPLIFIED ACQUISITION

Offers Received: 1

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Parent Company: Danaher Corporation

Address: 100 RESULTS WAY, MARLBOROUGH, MA, 01752

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Limited Liability Corporation, Manufacturer of Goods, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $47,187

Exercised Options: $47,187

Current Obligation: $47,187

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES

Timeline